NCT01936688
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012) treatment 3 withdrawn NCT01876875
n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis No drug interventions treatment 4 completed NCT01636687
Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) treatment 3 completed NCT01412944
Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis treatment 3 completed NCT01258088
Safety Study of Ointment for the Treatment of Plaque-type Psoriasis treatment 1 completed NCT00852761
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis treatment 4 completed NCT00763503
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis treatment 2 completed NCT02016105
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira treatment 3 completed NCT01132612
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis treatment 2 completed NCT00773734
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) treatment 2 completed NCT00625326
Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis treatment 2 completed NCT00521339
Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis treatment 2 completed NCT02660580
MSB11022 in Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT01646567
SHP-141C in Plaque Type Psoriasis treatment 1 completed NCT02339636
A Clinical Study of Subclinical Enthesitis and Synovitis in Patients With Vulgaris Psoriasis No drug interventions Not Available Not Available unknown_status NCT03806790
Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris treatment 3 completed NCT05488990
Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis treatment 1 / 2 completed NCT01022502
Comparison of Refined and Crude Indigo Naturalis Ointment in Treating Psoriasis treatment 2 completed NCT00691002
Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds treatment 3 completed NCT03795402
Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling No drug interventions Not Available Not Available completed NCT04099979
A Pilot Study to Explore the Role of Gut Flora in Psoriasis No drug interventions Not Available Not Available unknown_status NCT02125279
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis treatment 4 completed NCT02735187
Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D. treatment Not Available completed NCT04994951
Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome. treatment 2 unknown_status NCT03807453
Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis Patients No drug interventions Not Available Not Available completed NCT00875277
A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products other 2 completed NCT05820698
The Mediterranean Diet and Time-Restricted Eating Dietary Interventions for Psoriasis Study No drug interventions other Not Available recruiting NCT01229098
Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris treatment 2 completed NCT03942198
Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Stasis Syndrome No drug interventions treatment 2 unknown_status NCT05120297
A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis No drug interventions treatment 3 completed NCT04080661
Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients. No drug interventions treatment 4 completed NCT05215561
Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP No drug interventions Not Available Not Available active_not_recruiting NCT03402828
Body PSOriasis: Long-term Relapse CONTROL No drug interventions Not Available Not Available completed NCT03372811
Efficacy and Safety of TC Cream In Treating Patients With Psoriasis Vulgaris No drug interventions treatment 2 completed NCT00640393
Safety and Efficacy of Combining nbUVB to Etanercept in Patients treatment 4 completed NCT00236171
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test treatment Not Available completed NCT01580488
A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris Not Available 1 completed NCT02052609
A Phase 3 Clinical Study of KHK 4827 treatment 3 completed NCT00248456
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris treatment 4 completed NCT05461456
Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% treatment 1 completed NCT02577185
An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A other 1 completed NCT05683015
Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients No drug interventions treatment 4 recruiting NCT02193815
A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis treatment 1 completed NCT04533737
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab treatment 4 terminated NCT01982552
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life No drug interventions Not Available Not Available completed NCT03149900
Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients Not Available Not Available completed NCT03874975
Combined Oral Vitamin D and UVB Versus UVB Alone in Treatment of Psoriasis Vulgaris treatment 0 unknown_status NCT06203470
Botox Versus Tacrolimus in Psoriasis Vulgaris treatment 4 not_yet_recruiting NCT04207242
Social Media Use of Psoriasis Vulgaris Patients: Multicenter, Survey Work No drug interventions Not Available Not Available completed NCT03308799
A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream No drug interventions treatment 3 completed NCT05254249
Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris treatment 1 / 2 unknown_status NCT02132936
LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris treatment 3 completed NCT02753218
A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects other 1 terminated NCT01743118
Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris treatment 1 completed NCT03469219
Serum Granulysin Level as a Marker to Detect the Severity of Psoriasis No drug interventions Not Available Not Available unknown_status NCT00817219
Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris treatment 2 completed NCT00670241
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris treatment 3 completed NCT06257641
Impact of the Mediterranean Diet on Patients With Psoriasis No drug interventions treatment Not Available recruiting NCT01339741
Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency No drug interventions treatment Not Available unknown_status NCT03022617
A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis treatment 4 completed NCT03816917
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral No drug interventions Not Available Not Available completed NCT02990624
Cardiovascular Risk Evaluation in Psoriasis Treated With Photochemotherapy No drug interventions treatment Not Available completed NCT05499416
Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis treatment 4 withdrawn NCT04207216
Use of Alternative Therapy in Psoriasis Vulgaris Patients No drug interventions Not Available Not Available completed NCT05185258
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study basic_science 4 active_not_recruiting NCT02491658
Safety and Efficacy of UC-MSCs in Patients With Psoriasis Vulgaris treatment 1 / 2 unknown_status NCT04080635
Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO) No drug interventions treatment Not Available recruiting NCT03331835
A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis treatment 4 completed NCT01866163
LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris No drug interventions treatment 3 completed NCT01105286
A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis treatment 1 completed NCT01536886
LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris treatment 2 completed NCT06475586
Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus treatment 4 completed NCT04343586
Blue Light Phototherapy No drug interventions treatment Not Available completed NCT01946386
A Vasoconstriction Study With LEO 90100 treatment 1 completed NCT00640822
Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds treatment 3 completed NCT00277225
A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris treatment 1 completed NCT03669757
Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis treatment 1 completed NCT05144165
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines No drug interventions Not Available Not Available unknown_status NCT05102474
Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis No drug interventions Not Available Not Available recruiting NCT01320774
Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris Not Available Not Available completed NCT03025282
Safety and Efficacy of CD10367 in Psoriasis Vulgaris treatment 2 completed NCT01465282
Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris treatment 2 completed NCT04242082
Glucose Trnsporter and PEDF in Psoriasis No drug interventions Not Available Not Available unknown_status NCT06414382
PSODEEP2 Pilot Study on Koebner Induction in Psoriasis No drug interventions basic_science Not Available not_yet_recruiting NCT02317627
Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy treatment 2 completed NCT02715960
Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules treatment 2 unknown_status NCT02514694
LEO 32731 - A Phase I Study in Healthy Subjects other 1 completed NCT04418791
Modified Intermittent Fasting in Psoriasis No drug interventions treatment Not Available completed NCT03348462
Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis treatment 4 completed NCT04493762
Liver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on Methotrexate No drug interventions Not Available Not Available unknown_status NCT03885089
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) Not Available Not Available completed NCT02668692
LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis treatment 3 completed NCT03069144
Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis treatment 1 / 2 completed NCT03802344
This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream No drug interventions treatment 3 completed NCT05506644
Biofeedback for Psoriasis No drug interventions supportive_care Not Available completed NCT02636101
Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study Not Available Not Available completed NCT02038569
An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects No drug interventions treatment 2 completed NCT01935869
Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100 other 1 completed NCT04083612
Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients No drug interventions treatment 4 completed NCT04183881
A Phase 4 Clinical Study of Brodalumab treatment 4 completed NCT00845481
A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris Not Available 2 completed NCT01347255
A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris Not Available 2 completed NCT00924950
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis treatment 4 terminated NCT01443338
Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2 treatment 4 unknown_status NCT01536938
LEO 90100 in the Treatment of Psoriasis Vulgaris treatment 2 completed NCT05243303
Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation No drug interventions treatment Not Available recruiting NCT05442190
Topical SGX302 for Mild-to-Moderate Psoriasis treatment 2 recruiting NCT01735864
Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment treatment Not Available completed NCT03979664
Iontophoresis in Psoriasis treatment 0 withdrawn NCT06064084
Incretin Effect in Patients With Psoriasis and Controls No drug interventions Not Available Not Available completed NCT03389984
Psoriatic Inflammation Markers Predictive of Response to Adalimumab No drug interventions basic_science Not Available completed NCT05647187
Effect Narrow-Band UVB Radiations No drug interventions treatment Not Available completed NCT03553433
Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis treatment 4 unknown_status NCT04220554
Improvement of Psoriasis Patients' Adherence to Topical Drugs No drug interventions supportive_care Not Available completed NCT00764751
Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris treatment 2 completed NCT02796053
TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment treatment 1 / 2 completed NCT02387853
Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis No drug interventions treatment 2 completed NCT01607853
A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris Not Available 2 completed NCT00593177
A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis No drug interventions treatment 2 completed NCT03359577
Clinical Study to Investigate Psorax35 Supplementation in Patients With Psoriasis No drug interventions treatment Not Available completed NCT02004847
Blue Light for Treating Psoriasis Vulgaris No drug interventions treatment Not Available completed NCT03307447
Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT). treatment 4 unknown_status NCT06042647
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis treatment 4 completed NCT02715947
Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate treatment 2 unknown_status NCT00287547
Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris treatment 2 completed NCT01753245
Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice. No drug interventions Not Available Not Available unknown_status NCT05858645
Correction of Psoriatic T Cell Signatures by Deucravacitinib basic_science 4 recruiting NCT05906498
Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris treatment 3 recruiting NCT05815797
Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis No drug interventions treatment 2 not_yet_recruiting NCT06011083
Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis treatment Not Available completed NCT03898583
Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis. treatment 1 completed NCT04740983
Ultraviolet Radiation Forecasting Based Heliotherapy For Psoriasis in Bangkok, Thailand No drug interventions treatment Not Available unknown_status NCT01072383
Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis No drug interventions treatment 2 completed NCT06516783
Blue Light in the Treatment of Inflammatory Skin Diseases No drug interventions treatment Not Available completed NCT02902861
Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP) Not Available 3 completed NCT04750161
The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders No drug interventions Not Available Not Available unknown_status NCT01188928
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) treatment 3 completed NCT02126371
LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects Not Available 1 completed NCT03614078
A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis No drug interventions treatment 2 completed NCT00306878
Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris treatment 1 completed NCT01466478
An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris Not Available 1 completed NCT05079256
Laser Induced Changes to Innervation and Vascularisation of Psoriatic Skin No drug interventions treatment Not Available active_not_recruiting NCT03408756
Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis treatment 4 unknown_status NCT00678756
Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol treatment 2 unknown_status NCT03662685
Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris basic_science 4 active_not_recruiting NCT05390515
Psoriatic Immune Response to Tildrakizumab basic_science 4 recruiting NCT04306315
Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight treatment 4 recruiting NCT03322137
Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris treatment 2 completed NCT01936337
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients No drug interventions treatment 2 completed NCT05716152
Hormonal Associations in Male Patients With Psoriasis Vulgaris No drug interventions Not Available Not Available not_yet_recruiting NCT01651559
The Efficacy Of A Dead Sea Mineral Enriched Body Cream vs Its Carrier as an Adjuvant Treatment For Psoriatic Patients No drug interventions Not Available Not Available unknown_status NCT03675542
The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis. No drug interventions treatment 1 unknown_status NCT06191042
A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis No drug interventions treatment 1 recruiting NCT06398106
Proactive TDM Versus Standard Use of Biologics in Psoriasis treatment 4 not_yet_recruiting NCT02888236
LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris treatment 2 completed NCT04394936
An Explorative Psoriasis Biomarker Study treatment Not Available unknown_status NCT04028713
Dose Tapering Study of Adalimumab in Psoriasis No drug interventions treatment 4 terminated NCT01768013
The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris No drug interventions treatment 1 / 2 completed NCT03819218
A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects No drug interventions treatment 2 terminated NCT04950218
The Psoriasis Echo Study No drug interventions Not Available Not Available recruiting NCT00263718
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris treatment 2 completed NCT00816517
Use of Botulinum Toxin to Treat Psoriasis treatment 1 completed NCT01702324
Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study treatment 1 / 2 unknown_status NCT01043224
A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris treatment 1 completed NCT03231124
Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects. treatment 1 completed NCT04989296
Informative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With Psoriasis No drug interventions diagnostic Not Available completed NCT06563635
Frequency of Tuberculosis in Psoriasis Patients No drug interventions Not Available Not Available completed NCT01600222
Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris No drug interventions treatment 2 completed NCT00220025
Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris. No drug interventions treatment 1 completed NCT00365625
Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris No drug interventions Not Available Not Available unknown_status NCT03961230
Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome No drug interventions treatment 2 unknown_status NCT04095130
Tissue Sodium in Patients With Psoriasis No drug interventions Not Available Not Available completed NCT05184348
Plexin B2 Gene Expression and Polymorphisms in Psoriasis treatment 1 completed NCT04080648
Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients No drug interventions treatment 4 completed NCT02605057
Dermatopharmacokinetic Trial of LEO 80185 Gel other 1 completed NCT01831466
Tofacitinib Ointment For Chronic Plaque Psoriasis treatment 2 completed NCT01297166
A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris treatment 1 completed NCT02004574
Study for Treatment With Calcipotriol/Betamethasone Dipropionate Gel in Korean Patients With Psoriasis Vulgaris treatment 4 completed NCT02935582
PSOREAL - Managing PSOriasis in the REAL World Not Available Not Available completed NCT02533973
Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population treatment 4 completed NCT01268527
A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris treatment 2 completed NCT03462927
A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream No drug interventions treatment 2 completed NCT01837576
An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris Not Available 1 completed NCT04340076
Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis treatment 4 active_not_recruiting NCT02973776
Vasoconstriction Trial With LEO 90100 Aerosol Foam treatment 1 completed NCT03584360
Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin other 2 completed NCT03731091
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis). treatment 3 completed NCT01007591
A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas treatment 3 completed NCT02899962
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris No drug interventions treatment 3 completed NCT00704262
Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds treatment 2 completed NCT04541329
Predicting Inflammatory Skin Disease Response to IL-23 Blockade basic_science 4 completed NCT00216892
Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris treatment 4 completed NCT03442244
Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects No drug interventions other 1 completed NCT05685940
Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS) No drug interventions treatment 4 recruiting NCT05892640
Low-Salt Diet Effect on Th17-Mediated Inflammation and Vascular Reactivity in Psoriasis No drug interventions treatment Not Available recruiting NCT05311501
Impact of Non-surgical Periodontal Therapy in the Management of Plaque Psoriasis. No drug interventions treatment Not Available unknown_status NCT06508372
Topical Thymoquinone in Psoriasis Vulgaris treatment Not Available not_yet_recruiting NCT00833872
LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects No drug interventions Not Available 1 completed NCT01707368
Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation Not Available Not Available completed NCT04472546
Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis No drug interventions basic_science Not Available completed NCT02310646
Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris other 3 completed NCT03507946
Safety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis Vulgaris No drug interventions treatment Not Available unknown_status NCT03932110
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin Levels No drug interventions diagnostic Not Available completed NCT02088281
Mechanistic Study of Indigo Naturalis in Treating Psoriasis treatment 2 completed NCT01116895
A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris No drug interventions treatment 2 completed NCT02106195
A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris treatment 2 completed NCT04136314
Impact of Decision-Framing in Psoriasis No drug interventions health_services_research Not Available completed NCT05279638
ATG5 as a Serum Marker of Autophagy in Psoriatic Patient No drug interventions Not Available Not Available unknown_status NCT03828643
Secukinumab Efficacy Without the Initial Loading Dose in Patients With Psoriasis Not Available Not Available completed NCT01537432
Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients treatment 2 completed NCT06586112
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients with Moderate to Severe Plaque Psoriasis treatment 3 recruiting NCT06588738
A Study in Patients with Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 treatment 3 recruiting NCT03020199
Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis treatment 4 terminated NCT05375955
A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. treatment 2 completed NCT06122649
A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO) treatment 3 recruiting NCT06550076
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis treatment 3 recruiting NCT04772079
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis treatment 3 recruiting NCT05272150
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis treatment 3 active_not_recruiting NCT05364554
A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT05835843
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images No drug interventions Not Available Not Available active_not_recruiting NCT06088043
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment treatment 3 active_not_recruiting NCT06095102
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) No drug interventions treatment 3 active_not_recruiting NCT06095115
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis No drug interventions treatment 3 active_not_recruiting NCT06143878
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis treatment 3 active_not_recruiting NCT06176768
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis No drug interventions treatment 2 recruiting NCT06220604
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) treatment 3 active_not_recruiting NCT06542614
Treatment of Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 recruiting NCT06602219
A Study of LY4100511 (Dice 853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis No drug interventions treatment 2 not_yet_recruiting NCT01707043
Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris other 4 completed NCT04042103
Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis treatment 2 completed NCT02826603
Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis treatment 3 completed NCT03358290
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 terminated NCT00691964
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT05891964
Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital. treatment 4 completed NCT04855721
A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3) No drug interventions treatment 2 completed NCT06357221
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients treatment 4 active_not_recruiting NCT02494479
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis treatment 2 completed NCT05803187
Clinical Study of Stage IV Psoriasis in Children With Geleli No drug interventions Not Available Not Available recruiting NCT03591887
A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis treatment 2 completed NCT06382987
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect) Not Available Not Available recruiting NCT04172233
A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 1 / 2 completed NCT01726933
LAS41008 in Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT06382051
Modifying PEST for Psoriatic Arthritis Screening No drug interventions screening Not Available not_yet_recruiting NCT04571151
Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis treatment 4 unknown_status NCT04664153
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis treatment 2 completed NCT02129777
Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis treatment 2 completed NCT03506477
Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color treatment 4 completed NCT02045277
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis No drug interventions treatment 2 completed NCT02514577
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis No drug interventions treatment 3 completed NCT00608777
Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva) treatment 4 terminated NCT02908347
Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients No drug interventions treatment 2 completed NCT01882647
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305) No drug interventions treatment 3 completed NCT00302445
A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis treatment 4 completed NCT00871598
BTT1023 in Psoriasis treatment 1 completed NCT03630198
Pain Outcomes Following Intralesional Corticosteroid Injections treatment 4 completed NCT02701205
Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis treatment 3 unknown_status NCT04720105
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis treatment 4 completed NCT02112097
ASIS for Enbrel in Plaque Psoriasis treatment 1 / 2 unknown_status NCT03759197
A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis No drug interventions treatment 3 completed NCT01232283
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis. treatment 3 completed NCT02367911
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis No drug interventions treatment 3 completed NCT00796211
A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis treatment 2 completed NCT03848871
The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients treatment 4 completed NCT05282771
A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis. treatment 0 completed NCT02932878
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression No drug interventions treatment 2 completed NCT02899988
A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT05442788
A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis No drug interventions treatment 1 completed NCT04036188
Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis treatment 0 recruiting NCT04128007
Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis treatment 2 completed NCT04102007
A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab treatment 3 completed NCT03364309
A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis treatment 3 completed NCT04595409
A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis treatment 3 completed NCT03066609
Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis treatment 3 completed NCT06370156
Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients Not Available Not Available not_yet_recruiting NCT03065556
A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203) No drug interventions treatment 2 completed NCT01700985
A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis No drug interventions treatment 2 completed NCT05203315
Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults treatment 3 completed NCT03167515
A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis No drug interventions treatment Not Available completed NCT00747032
To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis No drug interventions treatment 3 withdrawn NCT06005532
Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira® treatment 3 recruiting NCT00581100
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis treatment 4 completed NCT01680159
A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis treatment 3 completed NCT05431959
Evaluation of the Effect of Sulphur Mineral, Thermal Water on Skin Microbiome in Plaque Psoriasis, a Pilot Study No drug interventions treatment Not Available unknown_status NCT04846959
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications Not Available Not Available recruiting NCT02618759
Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis No drug interventions treatment 3 completed NCT03764475
Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis treatment 2 completed NCT06488170
A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting Not Available Not Available recruiting NCT02749370
Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast treatment 4 completed NCT02462070
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis No drug interventions treatment 3 completed NCT02856542
Real-life Evaluation of the Daivobet® Gel Applicator Not Available Not Available completed NCT04018599
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS basic_science 1 completed NCT02749799
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis treatment 4 completed NCT03645499
An Open-Label Study to Assess Safety No drug interventions treatment 1 completed NCT06088199
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis treatment 3 recruiting NCT03339999
AGN-242428 in the Treatment of Plaque Psoriasis No drug interventions treatment 2 terminated NCT02561806
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis treatment 3 completed NCT00007306
Treatment of Psoriasis With Parathyroid Hormone treatment 1 / 2 completed NCT05600036
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis No drug interventions treatment 2 completed NCT02098213
Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis No drug interventions supportive_care Not Available completed NCT04279119
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis No drug interventions treatment 1 completed NCT01194219
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT02742441
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) No drug interventions treatment 3 completed NCT03858634
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases treatment 2 completed NCT05811234
A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults Not Available Not Available active_not_recruiting NCT02201524
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis treatment 2 terminated NCT01483924
Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis No drug interventions treatment 2 completed NCT01768858
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice Not Available Not Available completed NCT03638258
The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis treatment 2 completed NCT06338358
Understanding Participation Habits Among Plaque Psoriasis Patients No drug interventions Not Available Not Available not_yet_recruiting NCT00570986
A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT05072886
Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis No drug interventions treatment 1 active_not_recruiting NCT02462122
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis No drug interventions treatment 3 completed NCT06106230
Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint treatment Not Available completed NCT05172726
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects treatment 3 recruiting NCT00184366
Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis Not Available Not Available terminated NCT02070965
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT00371774
Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program No drug interventions Not Available Not Available completed NCT00428974
Safety and Efficacy Study of CF101 to Treat Psoriasis treatment 2 completed NCT05531682
A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT05344482
Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis No drug interventions Not Available Not Available completed NCT05763082
Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis treatment 3 completed NCT01722331
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010) treatment 3 completed NCT05896527
A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT04031027
A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice Not Available Not Available completed NCT04603027
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis treatment 2 completed NCT05994976
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers No drug interventions Not Available Not Available recruiting NCT03952676
Moving Cupping for Plaque Psoriasis: a Randomized Controlled Trial No drug interventions treatment Not Available unknown_status NCT05565560
A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis treatment 3 recruiting NCT04728360
Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT03055494
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients treatment 4 completed NCT04722094
Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study No drug interventions Not Available Not Available unknown_status NCT01875991
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept treatment 4 completed NCT01279629
Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis Not Available Not Available suspended NCT01708629
Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects treatment 3 terminated NCT00833729
The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab treatment 4 completed NCT01899729
A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT04537689
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis other 4 recruiting NCT03441789
Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis treatment 4 completed NCT02274792
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis treatment 4 completed NCT06108544
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period treatment 3 active_not_recruiting NCT06104644
A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany (DELPHIN) Not Available Not Available recruiting NCT05377944
Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients treatment 3 active_not_recruiting NCT02153840
Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque Psoriasis No drug interventions treatment Not Available terminated NCT00227240
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis No drug interventions Not Available Not Available completed NCT05078567
Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Plaque Psoriasis No drug interventions treatment Not Available unknown_status NCT02409667
Plaque Psoriasis Efficacy and Safety With Secukinumab treatment 3 completed NCT05855967
A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years with Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India treatment 4 active_not_recruiting NCT02634801
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment treatment 3 completed NCT05332704
Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685 No drug interventions treatment 1 completed NCT02340169
Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis treatment 4 completed NCT00884169
Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients Not Available 2 completed NCT05621369
Psorcast Mobile Study No drug interventions Not Available Not Available recruiting NCT01166646
Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis treatment 2 completed NCT04263610
Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy treatment 4 completed NCT03316781
Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT04339595
Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis treatment 4 terminated NCT01251614
A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate treatment 3 completed NCT04908514
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis No drug interventions treatment 2 completed NCT04645355
Guselkumab Immunogenetics treatment 4 recruiting NCT03956355
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001) treatment 3 completed NCT05357755
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT02310750
A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation Not Available 1 completed NCT06278350
Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis No drug interventions treatment 2 recruiting NCT03832738
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT01987843
Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis No drug interventions treatment 2 completed NCT04121143
A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults treatment 2 suspended NCT06336343
Bimekizumab in Plaque Psoriasis treatment 4 recruiting NCT03837743
Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis treatment 2 completed NCT06488664
An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis treatment 3 active_not_recruiting NCT03005964
Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis No drug interventions treatment 2 completed NCT03817164
Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis No drug interventions treatment Not Available unknown_status NCT01321164
Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis treatment 3 completed NCT00832364
Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis treatment 4 withdrawn NCT02192164
Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis No drug interventions Not Available Not Available completed NCT02527421
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis treatment 3 terminated NCT02486302
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. Not Available Not Available completed NCT01871402
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304) No drug interventions treatment 3 completed NCT02886702
A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis treatment 3 completed NCT03894579
Autologous Natural Killer Cells in Subjects With Plaque Psoriasis No drug interventions treatment 1 completed NCT01634087
A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis treatment 2 completed NCT04053387
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) treatment 3 completed NCT02243787
Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis No drug interventions treatment 1 / 2 terminated NCT04203433
A Study of DLX105-DMP in Subjects With Plaque Psoriasis No drug interventions treatment 1 completed NCT01698333
Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression No drug interventions treatment 2 completed NCT01729754
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011) treatment 3 completed NCT00733954
Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis treatment 4 completed NCT00708851
NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study No drug interventions treatment Not Available completed NCT04823247
Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study Not Available Not Available active_not_recruiting NCT06242847
Role of Insulin Action in Psoriasis Pathogenesis No drug interventions Not Available Not Available recruiting NCT01677598
A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries Not Available Not Available completed NCT02326298
An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) treatment 3 completed NCT02515097
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis No drug interventions treatment 3 completed NCT02462083
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis No drug interventions treatment 3 completed NCT03992261
Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis treatment 4 completed NCT03210961
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis treatment 1 completed NCT01140061
Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020) treatment 1 completed NCT05509361
Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis No drug interventions treatment 3 completed NCT02993328
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults treatment 2 withdrawn NCT01235728
A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022) treatment 1 completed NCT04594928
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis No drug interventions basic_science 1 completed NCT04746911
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) treatment 2 completed NCT04428411
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO). Not Available Not Available completed NCT04203693
Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice Not Available Not Available completed NCT06143371
A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis. No drug interventions treatment 1 recruiting NCT01566578
A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF No drug interventions treatment 1 unknown_status NCT02251678
Evaluate the Effect of Elimune Capsules No drug interventions basic_science 1 completed NCT03442088
Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast treatment 2 completed NCT06380907
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis No drug interventions treatment 2 recruiting NCT03000309
Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy treatment 4 completed NCT03018509
Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects No drug interventions treatment 1 completed NCT01228656
Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate treatment 2 suspended NCT03168256
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis treatment 3 completed NCT03953885
Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome No drug interventions treatment Not Available unknown_status NCT03589885
Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT05073315
A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT04453137
Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis other 3 completed NCT06512337
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China Not Available Not Available not_yet_recruiting NCT04173637
Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT00988637
Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis treatment 4 completed NCT04398732
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients Not Available Not Available completed NCT03731052
Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307) No drug interventions treatment 3 completed NCT00663052
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis treatment 4 completed NCT03073200
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis treatment 3 completed NCT04239859
Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis other 4 not_yet_recruiting NCT00852670
ACT-128800 in Psoriasis treatment 2 completed NCT02435342
A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis No drug interventions Not Available 1 completed NCT01010542
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects No drug interventions treatment 1 terminated NCT01938599
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis No drug interventions treatment 2 completed NCT05046899
Investigation With BiopH+Psoriasis Medical Bath in Subject With Mild to Moderate Plaque Psoriasis. No drug interventions treatment Not Available completed NCT04080206
A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis No drug interventions treatment 2 completed NCT00658606
Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects treatment 4 completed NCT05330936
Comparison of Cyanocobalamin in Avocado Oil Cream With Steroid Combination Ointment No drug interventions treatment 0 completed NCT04229836
Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE) treatment 4 completed NCT06396013
A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome. treatment 1 not_yet_recruiting NCT04655313
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215) treatment 2 completed NCT01670513
A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 No drug interventions treatment 1 / 2 unknown_status NCT00540618
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis treatment 2 completed NCT05368818
An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data Source No drug interventions Not Available Not Available completed NCT00402818
RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization No drug interventions Not Available Not Available terminated NCT05913817
The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. Not Available Not Available recruiting NCT01317017
Cell Responses to IFN-gamma basic_science 0 terminated NCT00746434
A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis treatment 2 withdrawn NCT04163016
A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) basic_science 1 completed NCT00669916
A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis basic_science 1 / 2 completed NCT04237116
A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) treatment 3 terminated NCT05268016
Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT01610596
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis treatment 2 completed NCT05739435
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis No drug interventions treatment 2 active_not_recruiting NCT05042635
Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine treatment Not Available not_yet_recruiting NCT03212963
Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05% other 4 terminated NCT05510063
Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 4 completed NCT03930186
A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy treatment 3 completed NCT00557739
Study of CRx-191 to Assess Activity in Plaque Psoriasis treatment 2 completed NCT03004339
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test treatment 1 completed NCT02486939
A Long Term Safety Extension Study (CHS-0214-05) treatment 3 completed NCT01301157
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients treatment 2 completed NCT05725057
Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis No drug interventions treatment 1 / 2 active_not_recruiting NCT05108766
A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis treatment 3 completed NCT02239666
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis No drug interventions Not Available Not Available completed NCT02160665
Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis treatment 3 completed NCT02186665
Plaque Psoriasis Study in Pediatric Subjects treatment 4 completed NCT05772520
The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis No drug interventions treatment 2 recruiting NCT02016482
A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis treatment 3 completed NCT03941431
Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine No drug interventions treatment 2 unknown_status NCT01646073
Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis treatment 3 completed NCT02489227
Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis treatment 3 completed NCT02752776
A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis. other 4 completed NCT06579976
Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index No drug interventions Not Available Not Available not_yet_recruiting NCT06030076
A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis Not Available Not Available recruiting NCT05650060
Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis Not Available Not Available completed NCT01777191
Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT03983980
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) treatment 3 completed NCT04607980
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT01989429
Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients treatment 3 completed NCT02413229
A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study No drug interventions treatment 2 completed NCT05036889
A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering From Plaque Psoriasis Through Clinical Utility and Health Outcomes. No drug interventions diagnostic Not Available unknown_status NCT02412644
Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis treatment 4 completed NCT02346240
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) treatment 3 completed NCT01766440
PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis treatment 4 completed NCT01265667
Trial of CF101 to Treat Patients With Psoriasis treatment 2 / 3 completed NCT01373567
A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis No drug interventions treatment 4 completed NCT01893567
Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05% treatment 4 completed NCT03849404
Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis treatment 3 completed NCT02326272
A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) treatment 3 completed NCT01556672
Adalimumab-psoriasis and Small Bowel Lesions treatment 4 completed NCT05223868
A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis No drug interventions treatment 2 completed NCT02011269
TSO for Plaque Psoriasis No drug interventions treatment 2 withdrawn NCT00927069
Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept treatment 3 completed NCT02601469
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis No drug interventions treatment 2 completed NCT01710046
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis treatment 2 completed NCT02881346
Efficacy and Tolerability of Enstilar® in Daily Practice Not Available Not Available completed NCT00555646
Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis treatment 2 terminated NCT06058546
Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis No drug interventions treatment 2 recruiting NCT00382512
A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis treatment 1 completed NCT02134210
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) treatment 3 completed NCT01558310
A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis treatment 4 unknown_status NCT02368210
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) No drug interventions treatment 3 completed NCT03298581
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis treatment 2 withdrawn NCT04053881
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice Not Available Not Available completed NCT02547714
Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A treatment 4 completed NCT00437255
Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis treatment 4 completed NCT02513550
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT01815723
Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis treatment 3 withdrawn NCT01111123
Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis treatment 4 completed NCT03573323
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis treatment 4 completed NCT03000608
A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis treatment 2 completed NCT01230138
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis treatment 2 completed NCT02611349
Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis treatment 3 recruiting NCT02615093
A Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis treatment 3 recruiting NCT03029741
Bioavailability of AZD0284 and IV Microtracer Study No drug interventions treatment 1 completed NCT03310320
Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis No drug interventions treatment 1 terminated NCT02976831
Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects No drug interventions treatment 1 completed NCT01891019
Thalidomide in the Treatment of Chronic Plaque Psoriasis. treatment 2 completed